Drugs: A Very Short Introduction

Drugs: A Very Short Introduction

Author: Les Iversen

Publisher: Oxford University Press

Published: 2016-06-16

Total Pages: 145

ISBN-13: 0191062960

DOWNLOAD EBOOK

The twentieth century saw a remarkable upsurge of research on drugs, with major advances in the treatment of bacterial and viral infections, heart disease, stomach ulcers, cancer, and mental illnesses. These, along with the introduction of the oral contraceptive, have altered all of our lives. There has also been an increase in the recreational use and abuse of drugs in the Western world. This Very Short Introduction, in its second edition, gives a non-technical account of how drugs work in the body. Reviewing both legal (alcohol, nicotine, and caffeine) and illegal drugs, Les Iversen discusses why some are addictive, and whether drug laws need reform. ABOUT THE SERIES: The Very Short Introductions series from Oxford University Press contains hundreds of titles in almost every subject area. These pocket-sized books are the perfect way to get ahead in a new subject quickly. Our expert authors combine facts, analysis, perspective, new ideas, and enthusiasm to make interesting and challenging topics highly readable.


Drugs: A Very Short Introduction

Drugs: A Very Short Introduction

Author: Leslie Iversen

Publisher: Oxford Paperbacks

Published: 2001-08-23

Total Pages: 144

ISBN-13: 9780192854315

DOWNLOAD EBOOK

The book gives a non-technical account of how drugs work in the body. During the twentieth century the introduction of new medicines for the treatment of infections, heart disease, cancer, and mental illnesses and the oral contraceptive have altered all of our lives. Both legal (alcohol, nicotine, and caffeine) and illegal recreational drugs are also reviewed.


Vicodin and OxyContin

Vicodin and OxyContin

Author: Christine Petersen

Publisher: Cavendish Square Publishing, LLC

Published: 2013-08-01

Total Pages: 64

ISBN-13: 1608708330

DOWNLOAD EBOOK

2017 brought a lot of big changes to America; one of most alarming changes was that several cities are in an all-out epidemic of OxyContin and Vicodin epidemic. People are dying from over-use and abuse. This book helps readers understand why these prescription drugs are dangerous when mis-used, and even dangerous when prescribed. Real-life stories of teens who used OxyContin and Vicodin and the realities they faced are shared so it really hits home for the teen reader. Advice on how to deal with peer pressure that teens face when choosing to say no is offered in a practical and friendly tone. An entire chapter is devoted to getting help.


Regulatory Affairs in the Pharmaceutical Industry

Regulatory Affairs in the Pharmaceutical Industry

Author: Javed Ali

Publisher: Academic Press

Published: 2021-11-14

Total Pages: 287

ISBN-13: 0128222239

DOWNLOAD EBOOK

Regulatory Affairs in the Pharmaceutical Industry is a comprehensive reference that compiles all the information available pertaining to regulatory procedures currently followed by the pharmaceutical industry. Designed to impart advanced knowledge and skills required to learn the various concepts of regulatory affairs, the content covers new drugs, generic drugs and their development, regulatory filings in different countries, different phases of clinical trials, and the submission of regulatory documents like IND (Investigational New Drug), NDA (New Drug Application) and ANDA (Abbreviated New Drug Application). Chapters cover documentation in the pharmaceutical industry, generic drug development, code of Federal Regulation (CFR), the ANDA regulatory approval process, the process and documentation for US registration of foreign drugs, the regulation of combination products and medical devices, the CTD and ECTD formats, and much more. Updated reference on drug approval processes in key global markets Provides comprehensive coverage of concepts and regulatory affairs Presents a concise compilation of the regulatory requirements of different countries Introduces the fundamentals of manufacturing controls and their regulatory importance


Medicinal Chemistry and Drug Design

Medicinal Chemistry and Drug Design

Author: Deniz Ekinci

Publisher: BoD – Books on Demand

Published: 2012-05-16

Total Pages: 421

ISBN-13: 9535105132

DOWNLOAD EBOOK

Over the recent years, medicinal chemistry has become responsible for explaining interactions of chemical molecules processes such that many scientists in the life sciences from agronomy to medicine are engaged in medicinal research. This book contains an overview focusing on the research area of enzyme inhibitors, molecular aspects of drug metabolism, organic synthesis, prodrug synthesis, in silico studies and chemical compounds used in relevant approaches. The book deals with basic issues and some of the recent developments in medicinal chemistry and drug design. Particular emphasis is devoted to both theoretical and experimental aspect of modern drug design. The primary target audience for the book includes students, researchers, biologists, chemists, chemical engineers and professionals who are interested in associated areas. The textbook is written by international scientists with expertise in chemistry, protein biochemistry, enzymology, molecular biology and genetics many of which are active in biochemical and biomedical research. We hope that the textbook will enhance the knowledge of scientists in the complexities of some medicinal approaches; it will stimulate both professionals and students to dedicate part of their future research in understanding relevant mechanisms and applications of medicinal chemistry and drug design.


Health Care Financing and Insurance

Health Care Financing and Insurance

Author: Francesco Paolucci

Publisher: Springer Science & Business Media

Published: 2010-10-28

Total Pages: 124

ISBN-13: 364210794X

DOWNLOAD EBOOK

As a contribution to the search for suitable and sustainable solutions to finance rising medical care expenditures, the book proposes a typology of healthcare financing and insurance schemes, based on the dimensions of basic vs. supplementary services and mandatory vs. voluntary coverage, to analyse the design and the complex interactions between various financing and insurance arrangements in several OECD countries. This study provides a better understanding of the strengths and weaknesses of the financial and organisational structures of different countries’ healthcare financing and insurance schemes. Its main contributions are the development of a novel and rigorous theoretical framework analysing the economic rationales for the optimal design of healthcare financing and insurance schemes, and an empirical and institutional analysis investigating the consequences for efficiency and affordability of the complex interactions between basic and supplementary sources of financing.